CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 80.96% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Open platformOpen platform

Sweden's Bure Equity 9M NAV per share rises on portfolio gains

By Reuters News


Overview

  • Sweden investment firm's net asset value per share rose 34.8% in first nine months

  • Group earnings after tax and EPS turned positive from losses a year earlier

  • Company highlighted strong portfolio gains, value adjustments and a SEK 19 mln divestment


Outlook

  • Company did not provide specific financial guidance for future quarters or full-year results


Result Drivers

  • PORTFOLIO GAINS - Co cited strong share price increases in Yubico, Mycronic and Vitrolife as key drivers of net asset value growth

  • MYCRONIC PERFORMANCE - Mycronic reported sales growth of 38% with all business areas showing double-digit growth, boosting order intake and financial results

  • UNLISTED ASSET VALUE ADJUSTMENTS - Positive value adjustment of SEK 225 mln mainly from Atle Investment Management and Nodica Group based on improved sales, profits and transactions


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

9M EPS

SEK 94.90

9M Net Income

SEK 7.10 bln

9M Net Asset Value

SEK 26.71 bln


Reuters Recommended Reads

  • Nov 5 - Sweden's Yubico Q3 net sales rise; appoints insider as deputy CEO

  • Nov 3 - Neostellar Capital Q3 NAV per share falls 6%

  • Nov 4 - Foresight Solar Fund Q3 NAV per share falls as discount rates increase


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.